Oral Cancer: Page 29

Vigilant raises $5.5M in funding
By DrBicuspid.com staff writers
Vigilant Biosciences has raised $5.5 million in Series B funding. The company intends to use the newly raised funds to get U.S. and European approval for its oral cancer device, the OncAlert oral cancer risk assessment system.
February 24, 2015
Researchers propose new staging model for HPV+ oropharyngeal cancer
By Donna Domino
Canadian researchers are proposing a new tumor-staging model for predicting outcomes and guiding treatments for patients with human papillomavirus (HPV)-related oropharyngeal cancer, according to a new study in the Journal of Clinical Oncology. Since HPV-related cancer differs significantly from smoking-related cancer, less-intensive treatment strategies may be more appropriate, the study found.
February 23, 2015
2013 11 25 12 43 56 283 Oral Pharynx Exam 200
Tufts dental school to add oral medicine residency program
By DrBicuspid.com staff writers
Tufts University School of Dental Medicine will begin enrolling students in its new Advanced Education Program in Oral Medicine in July 2016.
February 22, 2015
NCI awards $1M grant for 1st heavy ion radiation center in U.S.
By DrBicuspid.com staff writers
The National Cancer Institute (NCI) has awarded the University of Texas Southwestern a $1 million planning grant to develop research proposals for the first heavy ion radiation therapy research center in the U.S.
February 17, 2015
New tracer could help HNSCC patients avoid surgery
By Wayne Forrest
With the help of a novel radiotracer, researchers were able to accurately identify sentinel lymph nodes in patients with head and neck squamous cell carcinoma (HNSCC), potentially reducing the number of patients who need to undergo selective neck dissection.
February 15, 2015
2015 02 13 11 40 18 24 De Bree Hnscc 200
New research suggests possible cure for HPV+ oropharyngeal cancer
By Donna Domino
It may be possible for some patients with human papillomavirus-positive oropharyngeal cancer to be cured, even after the disease has spread to other organs, Canadian researchers reported today at the International Conference on Innovative Approaches in Head and Neck Oncology in Nice, France.
February 12, 2015
2013 09 03 14 41 25 490 Hpv 200
Lumina HealthCare offers oral brush biopsy test
By DrBicuspid.com staff writers
Lumina HealthCare, an onsite dental care services provider based in Los Angeles, has announced that it is now offering the oral brush biopsy diagnostic test.
February 11, 2015
Study produces 1st comprehensive genomic map of HNC
By Donna Domino
Researchers have identified genomic changes in head and neck cancers (HNCs) caused by human papillomavirus (HPV), according to a new study in the journal Nature. The findings could provide detailed explanations of how HPV infection and smoking play roles in HNC risk and disease development and also offer diagnostic and treatment therapies.
February 4, 2015
2013 09 03 14 41 25 490 Hpv 200
Family history of early cancer is HNC risk factor in young adults
By Donna Domino
In the largest investigation on the role of major risk factors for head and neck cancers (HNC) in young adults, researchers found that these cancers are more likely the result of inherited factors, rather than lifestyle factors such as smoking or drinking alcohol, according to a new study in the International Journal of Epidemiology.
February 2, 2015
2013 04 10 10 14 48 506 Cancer Cell 200
Dr. Califf named FDA deputy commissioner for medical products, tobacco
By DrBicuspid.com staff writers
Robert Califf, MD, has been appointed the FDA deputy commissioner for medical products and tobacco.
January 25, 2015
Football legend Jim Kelly now cancer-free
By DrBicuspid.com staff writers
After a recurrence of oral cancer in 2014, NFL Hall of Fame quarterback Jim Kelly is now cancer-free.
January 21, 2015
UB researchers develop device to find, destroy cancer cells
By DrBicuspid.com staff writers
Researchers at the University at Buffalo (UB) are designing a new biomedical device that could make chemotherapy more efficient, reduce its side effects, and improve the treatment of oral and other cancers.
January 21, 2015
Previous Page
Page 29 of 116
Next Page